IBDEI16K ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19153,1,4,0)
 ;;=4^J45.20
 ;;^UTILITY(U,$J,358.3,19153,2)
 ;;=^5008242
 ;;^UTILITY(U,$J,358.3,19154,0)
 ;;=J45.21^^64^851^18
 ;;^UTILITY(U,$J,358.3,19154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19154,1,3,0)
 ;;=3^Mild Intermittent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,19154,1,4,0)
 ;;=4^J45.21
 ;;^UTILITY(U,$J,358.3,19154,2)
 ;;=^5008243
 ;;^UTILITY(U,$J,358.3,19155,0)
 ;;=J45.31^^64^851^21
 ;;^UTILITY(U,$J,358.3,19155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19155,1,3,0)
 ;;=3^Mild Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,19155,1,4,0)
 ;;=4^J45.31
 ;;^UTILITY(U,$J,358.3,19155,2)
 ;;=^5008246
 ;;^UTILITY(U,$J,358.3,19156,0)
 ;;=J45.32^^64^851^22
 ;;^UTILITY(U,$J,358.3,19156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19156,1,3,0)
 ;;=3^Mild Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,19156,1,4,0)
 ;;=4^J45.32
 ;;^UTILITY(U,$J,358.3,19156,2)
 ;;=^5008247
 ;;^UTILITY(U,$J,358.3,19157,0)
 ;;=J45.30^^64^851^23
 ;;^UTILITY(U,$J,358.3,19157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19157,1,3,0)
 ;;=3^Mild Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,19157,1,4,0)
 ;;=4^J45.30
 ;;^UTILITY(U,$J,358.3,19157,2)
 ;;=^5008245
 ;;^UTILITY(U,$J,358.3,19158,0)
 ;;=J45.41^^64^851^24
 ;;^UTILITY(U,$J,358.3,19158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19158,1,3,0)
 ;;=3^Moderate Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,19158,1,4,0)
 ;;=4^J45.41
 ;;^UTILITY(U,$J,358.3,19158,2)
 ;;=^5008249
 ;;^UTILITY(U,$J,358.3,19159,0)
 ;;=J45.42^^64^851^25
 ;;^UTILITY(U,$J,358.3,19159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19159,1,3,0)
 ;;=3^Moderate Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,19159,1,4,0)
 ;;=4^J45.42
 ;;^UTILITY(U,$J,358.3,19159,2)
 ;;=^5008250
 ;;^UTILITY(U,$J,358.3,19160,0)
 ;;=J45.40^^64^851^26
 ;;^UTILITY(U,$J,358.3,19160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19160,1,3,0)
 ;;=3^Moderate Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,19160,1,4,0)
 ;;=4^J45.40
 ;;^UTILITY(U,$J,358.3,19160,2)
 ;;=^5008248
 ;;^UTILITY(U,$J,358.3,19161,0)
 ;;=J41.1^^64^851^27
 ;;^UTILITY(U,$J,358.3,19161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19161,1,3,0)
 ;;=3^Mucopurulent Chr Bronchitis
 ;;^UTILITY(U,$J,358.3,19161,1,4,0)
 ;;=4^J41.1
 ;;^UTILITY(U,$J,358.3,19161,2)
 ;;=^269949
 ;;^UTILITY(U,$J,358.3,19162,0)
 ;;=J45.998^^64^851^2
 ;;^UTILITY(U,$J,358.3,19162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19162,1,3,0)
 ;;=3^Asthma NEC
 ;;^UTILITY(U,$J,358.3,19162,1,4,0)
 ;;=4^J45.998
 ;;^UTILITY(U,$J,358.3,19162,2)
 ;;=^5008257
 ;;^UTILITY(U,$J,358.3,19163,0)
 ;;=J43.8^^64^851^15
 ;;^UTILITY(U,$J,358.3,19163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19163,1,3,0)
 ;;=3^Emphysema NEC
 ;;^UTILITY(U,$J,358.3,19163,1,4,0)
 ;;=4^J43.8
 ;;^UTILITY(U,$J,358.3,19163,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,19164,0)
 ;;=J43.1^^64^851^28
 ;;^UTILITY(U,$J,358.3,19164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19164,1,3,0)
 ;;=3^Panlobular Emphysema
 ;;^UTILITY(U,$J,358.3,19164,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,19164,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,19165,0)
 ;;=J45.51^^64^851^29
 ;;^UTILITY(U,$J,358.3,19165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19165,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,19165,1,4,0)
 ;;=4^J45.51
 ;;^UTILITY(U,$J,358.3,19165,2)
 ;;=^5008252
